Search results
Results from the WOW.Com Content Network
Organ trade (also known as the blood market or the red market) is the trading of human organs, tissues, or other body products, usually for transplantation. [1] [2] According to the World Health Organization (WHO), organ trade is a commercial transplantation where there is a profit, or transplantations that occur outside of national medical systems.
Organ theft is the act of taking a person's organs for transplantation or sale on the black market, without their explicit consent through means of being an organ donor or other forms of consent. Most cases of organ theft involve coercion, occurrences in wartime, or thefts within hospital settings. [ 1 ]
This list is not limited to drugs that were ever approved by the FDA. Some of them (lumiracoxib, rimonabant, tolrestat, ximelagatran and ximelidine, for example) were approved to be marketed in Europe but had not yet been approved for marketing in the US, when side effects became clear and their developers pulled them from the market.
Akkina is one of the researchers involved with a phase 3 trial in organ transplant patients that uses stem cells taken from the organ donor in an attempt to wean the recipients off of these drugs ...
The following list encompasses notable medicine contamination and adulteration incidents. 1937 Elixir sulfanilamide incident: S. E. Massengill Company used diethylene glycol as the solvent for the antibacterial sulfanilamide , leading to the 1938 passage of the Federal Food, Drug, and Cosmetic Act .
For premium support please call: 800-290-4726 more ways to reach us
The growth of a commercial organ trade is linked to economic reforms in the late 1980s and early 1990s that saw a steep decline in government funding to the healthcare system. Healthcare moved toward a more market-driven model, and hospitals devised new ways to grow their revenue.
For premium support please call: 800-290-4726 more ways to reach us